{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:18:55Z","timestamp":1770909535036,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T00:00:00Z","timestamp":1617408000000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.chest.2019.11.021","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T05:11:33Z","timestamp":1585890693000},"page":"e107-e109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Venoocclusive Disease With Both Hepatic and Pulmonary Involvement"],"prefix":"10.1016","volume":"157","author":[{"given":"No\u00e9mie","family":"Tissot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Montani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-France","family":"Seronde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Degano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibaud","family":"Soumagne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.chest.2019.11.021_bib1","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1183\/13993003.00026-2016","article-title":"Pulmonary veno-occlusive disease","volume":"47","author":"Montani","year":"2016","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.chest.2019.11.021_bib2","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/bmt.2016.130","article-title":"Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation","volume":"51","author":"Mohty","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.chest.2019.11.021_bib3","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","author":"Simonneau","year":"2018","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.chest.2019.11.021_bib4","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/CIRCULATIONAHA.115.014207","article-title":"Mitomycin-induced pulmonary veno-occlusive disease: evidence from human disease and animal models","volume":"132","author":"Perros","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.chest.2019.11.021_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4137\/CMO.S26537","article-title":"Gemcitabine-induced pulmonary toxicity: a case report of pulmonary veno-occlusive disease","volume":"9","author":"Turco","year":"2015","journal-title":"Clin Med Insights Oncol"},{"issue":"8","key":"10.1016\/j.chest.2019.11.021_bib6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.bmt.1705990","article-title":"Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction","volume":"41","author":"Bunte","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.chest.2019.11.021_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2213-2600(16)30438-6","article-title":"Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study","volume":"5","author":"Montani","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.chest.2019.11.021_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.chest.2019.11.021_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/17512433.2018.1421943","article-title":"Defibrotide sodium for the treatment of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"11","author":"Richardson","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.chest.2019.11.021_bib10","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ajpath.2019.02.007","article-title":"Understanding the similarities and differences between hepatic and pulmonary veno-occlusive disease","volume":"189","author":"Gunther","year":"2019","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.chest.2019.11.021_bib11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ajpath.2014.10.021","article-title":"Chemotherapy-induced pulmonary hypertension: role of alkylating agents","volume":"185","author":"Ranchoux","year":"2015","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.chest.2019.11.021_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1183\/09031936.00157707","article-title":"Pulmonary veno-occlusive disease in myeloproliferative disorder","volume":"33","author":"Willems","year":"2009","journal-title":"Eur Respir J"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369219343727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369219343727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:20:29Z","timestamp":1757924429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369219343727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0012369219343727"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2019.11.021","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venoocclusive Disease With Both Hepatic and Pulmonary Involvement","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2019.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}